Molnupiravir The FDA has authorized an antiviral drug called molnupiravir. Molnupiravir treats mild to moderate COVID-19 in adults at higher risk of serious illness who can't take other treatments.

Adam Kovalčík, a 19-year-old from Slovakia, secured a top prize at an international science competition. He developed a ...

A viewer tells us they've been diagnosed with Covid-19, and they want to know if they need to take one of the Covid-19 antiviral medications. Doctor Lacy Anderson has the answer.

With COVID-19 cases again on the upswing, the antiviral Paxlovid has been slow to gain traction among patients and doctors even though the medication reduces hospitalizations and deaths. A recent ...

Scientists are currently studying how well people are protected against severe disease from XFG. Researchers conducted lab studies using human cells and a "pseudovirus" stand-in for XFG, as well as ...

Pfizer reported $12.5 billion in Paxlovid and COVID-19 vaccine sales in 2023, after a $57 billion peak in 2022.

COVID Virus Is Evolving Resistance to Antiviral Treatment, Studies Show Published Sep 26, 2024 at 8:15 AM EDT Updated Sep 26, 2024 at 11:42 AM EDT By Pandora Dewan ...

Since COVID-19 first spread rapidly around the world in 2020, we have significantly more options to reduce the symptoms and severity of the virus. COVID-19 symptoms usually begin in the first five ...

The study, published in the Journal of Virology, offers new information about late-onset treatment introduced 14 days after infection with SARS-CoV-2, the virus that causes COVID-19.

We must defeat the next pandemic before it emerges COVID-19’s anniversary illustration by Linas Garsys / The Washington Times more > Print Commentary By Robert Housman - Wednesday, December 25, 2024 ...

New York City has begun offering free, same day at-home delivery of COVID-19 antiviral pills to eligible residents although supplies remain limited. The program was announced by Mayor Eric Adams ...